|
|
|
Volumn 19, Issue 12, 2002, Pages 544-553
|
|
Is there a pipeline?
|
|
Author keywords
AIDS; Drug development; HIV
|
|
Indexed keywords
3' FLUOROTHYMIDINE;
6 CHLORO 4 (2 CYCLOPROPYLVINYL) 3,4 DIHYDRO 4 TRIFLUOROMETHYL 2(1H) QUINAZOLINONE;
ABACAVIR;
AMDOXOVIR;
AMPRENAVIR;
AMPRENAVIR PHOSPHATE;
ANTIRETROVIRUS AGENT;
ATAZANAVIR;
CAPRAVIRINE;
DARUNAVIR;
EFAVIRENZ;
ELVUCITABINE;
EMTRICITABINE;
ENFUVIRTIDE;
ETRAVIRINE;
GS 7340;
LAMIVUDINE;
NELFINAVIR;
PRO 140;
PROTEINASE INHIBITOR;
RECEPTOR BLOCKING AGENT;
RITONAVIR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
SCH C;
STAVUDINE;
T 1249;
TENOFOVIR;
TIPRANAVIR;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VICRIVIROC;
ARTICLE;
CENTRAL NERVOUS SYSTEM DISEASE;
CLINICAL TRIAL;
DRUG FORMULATION;
DRUG HALF LIFE;
DRUG HYPERSENSITIVITY;
DRUG POTENTIATION;
EYE TOXICITY;
GASTROINTESTINAL DISEASE;
GILBERT DISEASE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LACTIC ACIDOSIS;
LIPOATROPHY;
NONHUMAN;
SUBCUTANEOUS NODULE;
|
|
EID: 0036906237
PISSN: 07496524
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|
